Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration

• Published in: Alzheimer's & dementia Vol. 21; no. 8; pp. e70497 - n/a
• Main Authors: Palacios, Adrián G., Zhang, Sarah X., Acosta, Mónica L.
• Format: Journal Article
• Language: English
• Published: United States John Wiley and Sons Inc 01.08.2025
• Subjects: aging; Alzheimer Disease - metabolism; Alzheimer's disease; Animals; diabetes; Diabetic Retinopathy - metabolism; Endoplasmic Reticulum Stress; Humans; Oxidative Stress; retina; Review; unfolded protein response; Unfolded Protein Response - physiology; unfolded protein response; aging; retina; Alzheimer's disease; diabetes
• ISSN: 1552-5260; 1552-5279; 1552-5279
• DOI: 10.1002/alz.70497

Diabetic retinopathy (DR) and Alzheimer's disease (AD) are progressive neurodegenerative disorders affecting the eye and the brain, respectively. Despite targeting different organs, they share common molecular mechanisms. A central process connecting these conditions is the unfolded protein response (UPR), which maintains protein homeostasis in the endoplasmic reticulum (ER). Dysregulation of UPR pathways, particularly the IRE1‐XBP1 and PERK‐eIF2α pathways, can lead to inflammation, oxidative stress, and neurodegeneration. While the IRE1‐XBP1 pathway regulates protein folding and inflammatory signaling, the PERK‐eIF2α pathway reduces protein synthesis but may trigger apoptosis if persistently activated. Emerging therapies targeting UPR pathways and ER chaperones show promise in mitigating neurodegenerative damage in DR and AD. This review highlights shared pathophysiological mechanisms, explore retinal biomarkers for early AD detection, and emphasizes UPR modulation as a therapeutic strategy for neurodegeneration in aging‐related diseases. Highlights Diabetic retinopathy (DR, ocular disorder) and Alzheimer's disease (AD, cerebral disorder) share common molecular mechanisms, including oxidative stress, inflammation, and proteostasis dysfunction. UPR is a critical pathway linking both diseases through endoplasmic reticulum (ER) stress and neurodegeneration and targeting unfolded protein response (UPR) pathways, ER chaperones (e.g., P58IPK), and anti‐inflammatory treatments show promise. The IRE1‐XBP1 pathway regulates protein homeostasis and inflammation; XBP1s protects against ER stress in both retinal and brain neurons. The PERK‐eIF2α pathway suppresses protein synthesis under stress but may induce apoptosis via ATF4 and CHOP if chronically activated. Age‐related decline in metabolism, proteostasis, and neurovascular function intensifies disease progression and exacerbates molecular and cellular damage in both DR and AD.